(Q43864995)

27 November 2017

Emerging roles of endoglin/CD105 and angiogenic cytokines for disease development and progression in multiple myeloma patients (English)

1 reference

27 November 2017

C A Pappa

1

1 reference

27 November 2017

M G Alexandrakis

2

1 reference

27 November 2017

A Boula

3

1 reference

27 November 2017

F E Psarakis

4

1 reference

27 November 2017

A Kolovou

5

1 reference

27 November 2017

V Bantouna

6

1 reference

27 November 2017

E Stavroulaki

7

1 reference

27 November 2017

G Tsirakis

8

1 reference

27 November 2017

11 April 2013

1 reference

27 November 2017

Hematological Oncology

1 reference

27 November 2017

31

1 reference

27 November 2017

4

1 reference

27 November 2017

201-205

1 reference

CD105 is important for angiogenesis: evidence and potential applications

27 November 2017

1 reference

Inducible expression of human endoglin during inflammation and wound healing in vivo

21 January 2018

1 reference

Alterations in components of the TGF-beta superfamily signaling pathways in human cancer

21 January 2018

1 reference

21 January 2018

1 reference

Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis.

21 January 2018

1 reference

Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies

21 January 2018

1 reference

Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer

21 January 2018

1 reference

Soluble endoglin contributes to the pathogenesis of preeclampsia

21 January 2018

1 reference

Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer

21 January 2018

1 reference

Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growth

21 January 2018

1 reference

21 January 2018

1 reference

Clinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancer

21 January 2018

1 reference

Interleukin-18 in multiple myeloma patients: serum levels in relation to response to treatment and survival

21 January 2018

1 reference

Interleukin 18 induces angiogenesis in vitro and in vivo via Src and Jnk kinases.

21 January 2018

1 reference

Angiogenesis and apoptosis

21 January 2018

1 reference

Cytokines and chemokines as regulators of angiogenesis in health and disease

21 January 2018

1 reference

VEGF-R2 and neuropilin-1 are involved in VEGF-A-induced differentiation of human bone marrow progenitor cells

21 January 2018

1 reference

Origin of endothelial progenitors in human postnatal bone marrow

21 January 2018

1 reference

Angiogenesis in life, disease and medicine

21 January 2018

1 reference

Angiogenesis markers quantification in breast cancer and their correlation with clinicopathological prognostic variables

21 January 2018

1 reference

The combination of bortezomib, melphalan, dexamethasone and intermittent thalidomide is an effective regimen for relapsed/refractory myeloma and is associated with improvement of abnormal bone metabolism and angiogenesis

21 January 2018

1 reference

Relation between bone marrow angiogenesis and serum levels of angiogenin in patients with myelodysplastic syndromes

21 January 2018

1 reference

Levels of soluble angiogenin in chronic myeloid malignancies: clinical implications.

21 January 2018

1 reference

Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer

21 January 2018

1 reference

Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence.

21 January 2018

1 reference

Soluble angiogenesis markers in gastric tumor patients.

21 January 2018

1 reference

Differential levels of soluble endoglin (CD105) in myeloid malignancies

21 January 2018

1 reference

High levels of serum angiogenic growth factors in patients with AL amyloidosis: comparisons with normal individuals and multiple myeloma patients

21 January 2018

1 reference

The role of the TGF-β coreceptor endoglin in cancer

21 January 2018

1 reference

7 January 2021

Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways

1 reference

7 January 2021

Expression, purification and characterization of recombinant human angiogenin in Pichia pastoris

1 reference

7 January 2021

Elevated serum angiogenin in multiple myeloma

1 reference

7 January 2021

Clinical significance of sCD105 in angiogenesis and disease activity in multiple myeloma

1 reference

7 January 2021

Identifiers

DOI

10.1002/HON.2044

1 reference

27 November 2017

1 reference